Plant Health Care PLC First US patent issues for PREtec peptide products
23 Enero 2020 - 01:00AM
RNS Non-Regulatory
TIDMPHC
Plant Health Care PLC
23 January 2020
23 January 2020
PLANT HEALTH CARE plc
("Plant Health Care" or the "Company")
First US patent issues for PREtec peptide products
Plant Health Care(R) , a leading provider of novel
patent-protected biological products to global agriculture markets
with a strong track record of successful commercialisation of new
technologies, is pleased to announce the granting of the first US
patent on its novel PREtec peptide technology.
Highlights:
- Plant Health Care has filed more than 50 patent applications
worldwide for its PREtec peptide technology since 2012
- The first of these patents has now been granted by the US
Patent and Trademark Office (USPTO)
- The patent provides protection for a series of PREtec peptides
in a wide range of agricultural uses
- Additional patents are expected to be granted over the coming
months
- The Company is planning to commercialise PREtec peptides into
market opportunities worth more than $5bn
Plant Health Care is developing novel peptide products from the
PREtec (Plant Response Elicitor) platform. These products act as
'vaccines for plants'; they stimulate the plant to defend itself
from stress, such as disease and drought, leading to better quality
and higher yield at harvest. Derived from natural proteins, PREtec
peptides are a novel, environmentally friendly approach to
protecting crops and increasing yields, compatible with mainstream
agricultural practices. The Company is initially targeting market
opportunities worth more than $5bn.
US patent No. 10,470,461, issued November 12, 2019, claims a
large number of unique response elicitor peptides, as well as their
use in combination with other agricultural products to enhance
disease resistance, improve plant growth, and impart tolerance to
both biotic stresses and abiotic stresses such as heat, drought,
and excess soil salinity.
Zhongmin Wei, Ph.D., Chief Scientific Officer for Plant Health
Care and inventor of the PREtec technology said, "I am pleased that
the USPTO has recognized the patentability of the response elicitor
peptide sequences and their use for agricultural production. This
is the first of a series of patents that we expect will issue
shortly. Plant Health Care is carving out a dominant patent
position around the use of response elicitor peptides in
agriculture."
Chris Richards, CEO of Plant Health Care, said, "Receiving this
patent is another significant milestone in our path to bringing
PREtec peptides to commercial sales. Alongside our recently
announced progress at scaling up manufacture of our lead peptide,
PHC279, and the exciting results shown for the control of Asian
Soybean Rust (ASR) in Brazil, this further boosts our confidence
about the commercial potential for PREtec based products. We are
preparing to launch this novel technology directly to markets in
USA, Brazil and other countries, once regulatory permits are in
place."
For further information, please contact:
Plant Health Care plc
Chris Richards, CEO Tel: +1 919 926 1600
Jeff Tweedy, COO Tel: +1 919 926 1600
Arden Partners plc - Nomad and Broker
John Llewellyn-Lloyd / Dan Gee-Summons (Corporate Finance) Tel:
+44 (0) 20 7614 5900
Fraser Marshall (Equity Sales)
Company website: www.planthealthcare.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAGZGZMGZFGGZZ
(END) Dow Jones Newswires
January 23, 2020 02:00 ET (07:00 GMT)
Plant Health Care (LSE:PHC)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Plant Health Care (LSE:PHC)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024